share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Oosthuizen Johannes Jacobus

SEC announcement ·  Feb 6 05:04
Summary by Futu AI
On February 2, 2024, Johannes Jacobus Oosthuizen, President of U.S. Market for Merck & Co., Inc. [MRK], completed a series of transactions involving the company's common stock. Oosthuizen acquired a total of 20,937 shares through the exercise or conversion of derivative securities at prices ranging from $73.73 to $87.10. On the same day, he disposed of 18,959 shares in an open market sale at a price of $127.175 per share, resulting in a total market value of $2,411,110.82. Following these transactions, Oosthuizen's direct holdings in Merck & Co. amounted to 23,327.345 shares of common stock.
On February 2, 2024, Johannes Jacobus Oosthuizen, President of U.S. Market for Merck & Co., Inc. [MRK], completed a series of transactions involving the company's common stock. Oosthuizen acquired a total of 20,937 shares through the exercise or conversion of derivative securities at prices ranging from $73.73 to $87.10. On the same day, he disposed of 18,959 shares in an open market sale at a price of $127.175 per share, resulting in a total market value of $2,411,110.82. Following these transactions, Oosthuizen's direct holdings in Merck & Co. amounted to 23,327.345 shares of common stock.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.